nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—ORM1—Vemurafenib—melanoma	0.365	0.828	CbGbCtD
Amoxapine—CYP2D6—Vemurafenib—melanoma	0.0756	0.172	CbGbCtD
Amoxapine—Tongue discolouration—Temozolomide—melanoma	0.00445	0.0228	CcSEcCtD
Amoxapine—Vasculitis—Vemurafenib—melanoma	0.00431	0.0221	CcSEcCtD
Amoxapine—Drug fever—Docetaxel—melanoma	0.00429	0.022	CcSEcCtD
Amoxapine—Cerebration impaired—Temozolomide—melanoma	0.00366	0.0188	CcSEcCtD
Amoxapine—Atrial fibrillation—Vemurafenib—melanoma	0.00322	0.0165	CcSEcCtD
Amoxapine—Extrapyramidal disorder—Temozolomide—melanoma	0.00286	0.0146	CcSEcCtD
Amoxapine—Petechiae—Temozolomide—melanoma	0.00261	0.0134	CcSEcCtD
Amoxapine—Eosinophilia—Vemurafenib—melanoma	0.00261	0.0134	CcSEcCtD
Amoxapine—Menstruation irregular—Docetaxel—melanoma	0.00258	0.0132	CcSEcCtD
Amoxapine—Disturbance in attention—Temozolomide—melanoma	0.00248	0.0127	CcSEcCtD
Amoxapine—Lacrimation—Docetaxel—melanoma	0.00243	0.0125	CcSEcCtD
Amoxapine—Coordination abnormal—Carmustine—melanoma	0.00227	0.0116	CcSEcCtD
Amoxapine—Coordination abnormal—Temozolomide—melanoma	0.00219	0.0112	CcSEcCtD
Amoxapine—Disorientation—Bleomycin—melanoma	0.00207	0.0106	CcSEcCtD
Amoxapine—Gynaecomastia—Carmustine—melanoma	0.00199	0.0102	CcSEcCtD
Amoxapine—Mental disability—Carmustine—melanoma	0.00193	0.0099	CcSEcCtD
Amoxapine—Cerebrovascular accident—Bleomycin—melanoma	0.00189	0.00968	CcSEcCtD
Amoxapine—Alopecia—Vemurafenib—melanoma	0.00187	0.00958	CcSEcCtD
Amoxapine—Mental disability—Temozolomide—melanoma	0.00187	0.00957	CcSEcCtD
Amoxapine—Dysgeusia—Vemurafenib—melanoma	0.0018	0.00924	CcSEcCtD
Amoxapine—Vascular purpura—Temozolomide—melanoma	0.00175	0.00895	CcSEcCtD
Amoxapine—Nasal congestion—Temozolomide—melanoma	0.00171	0.00879	CcSEcCtD
Amoxapine—Purpura—Temozolomide—melanoma	0.00162	0.00831	CcSEcCtD
Amoxapine—Lacrimation increased—Docetaxel—melanoma	0.00155	0.00796	CcSEcCtD
Amoxapine—Ataxia—Carmustine—melanoma	0.00152	0.00779	CcSEcCtD
Amoxapine—Ataxia—Temozolomide—melanoma	0.00147	0.00753	CcSEcCtD
Amoxapine—Acute coronary syndrome—Bleomycin—melanoma	0.00141	0.00721	CcSEcCtD
Amoxapine—Hypotension—Vemurafenib—melanoma	0.0014	0.00719	CcSEcCtD
Amoxapine—Myocardial infarction—Bleomycin—melanoma	0.0014	0.00717	CcSEcCtD
Amoxapine—Stomatitis—Bleomycin—melanoma	0.00139	0.00713	CcSEcCtD
Amoxapine—Decreased appetite—Vemurafenib—melanoma	0.00131	0.00669	CcSEcCtD
Amoxapine—Stomatitis—Dactinomycin—melanoma	0.0013	0.00665	CcSEcCtD
Amoxapine—Fatigue—Vemurafenib—melanoma	0.00129	0.00664	CcSEcCtD
Amoxapine—Constipation—Vemurafenib—melanoma	0.00128	0.00658	CcSEcCtD
Amoxapine—Hypoaesthesia—Bleomycin—melanoma	0.00127	0.00653	CcSEcCtD
Amoxapine—Pollakiuria—Temozolomide—melanoma	0.00125	0.00639	CcSEcCtD
Amoxapine—Erectile dysfunction—Temozolomide—melanoma	0.00124	0.00637	CcSEcCtD
Amoxapine—Agranulocytosis—Dactinomycin—melanoma	0.00124	0.00637	CcSEcCtD
Amoxapine—Weight increased—Temozolomide—melanoma	0.00123	0.0063	CcSEcCtD
Amoxapine—Stomatitis—Carmustine—melanoma	0.00121	0.00622	CcSEcCtD
Amoxapine—Hepatitis—Dactinomycin—melanoma	0.00119	0.00612	CcSEcCtD
Amoxapine—Body temperature increased—Vemurafenib—melanoma	0.00119	0.00609	CcSEcCtD
Amoxapine—Stomatitis—Temozolomide—melanoma	0.00117	0.00601	CcSEcCtD
Amoxapine—Alopecia—Bleomycin—melanoma	0.00113	0.0058	CcSEcCtD
Amoxapine—Hypoaesthesia—Carmustine—melanoma	0.00111	0.0057	CcSEcCtD
Amoxapine—Hallucination—Carmustine—melanoma	0.00111	0.0057	CcSEcCtD
Amoxapine—Atrial fibrillation—Docetaxel—melanoma	0.0011	0.00562	CcSEcCtD
Amoxapine—Hepatitis—Temozolomide—melanoma	0.00108	0.00554	CcSEcCtD
Amoxapine—Asthenia—Vemurafenib—melanoma	0.00108	0.00552	CcSEcCtD
Amoxapine—Hypoaesthesia—Temozolomide—melanoma	0.00107	0.00551	CcSEcCtD
Amoxapine—Hallucination—Temozolomide—melanoma	0.00107	0.00551	CcSEcCtD
Amoxapine—Pruritus—Vemurafenib—melanoma	0.00106	0.00545	CcSEcCtD
Amoxapine—Alopecia—Dactinomycin—melanoma	0.00106	0.00541	CcSEcCtD
Amoxapine—Diarrhoea—Vemurafenib—melanoma	0.00103	0.00527	CcSEcCtD
Amoxapine—Tinnitus—Temozolomide—melanoma	0.00101	0.00516	CcSEcCtD
Amoxapine—Leukopenia—Bleomycin—melanoma	0.000998	0.00512	CcSEcCtD
Amoxapine—Dizziness—Vemurafenib—melanoma	0.000993	0.00509	CcSEcCtD
Amoxapine—Alopecia—Carmustine—melanoma	0.000988	0.00506	CcSEcCtD
Amoxapine—Ataxia—Docetaxel—melanoma	0.000976	0.00501	CcSEcCtD
Amoxapine—Vomiting—Vemurafenib—melanoma	0.000955	0.0049	CcSEcCtD
Amoxapine—Alopecia—Temozolomide—melanoma	0.000954	0.00489	CcSEcCtD
Amoxapine—Rash—Vemurafenib—melanoma	0.000947	0.00485	CcSEcCtD
Amoxapine—Dermatitis—Vemurafenib—melanoma	0.000946	0.00485	CcSEcCtD
Amoxapine—Headache—Vemurafenib—melanoma	0.000941	0.00482	CcSEcCtD
Amoxapine—Leukopenia—Dactinomycin—melanoma	0.000931	0.00477	CcSEcCtD
Amoxapine—Dysgeusia—Temozolomide—melanoma	0.000921	0.00472	CcSEcCtD
Amoxapine—Confusional state—Bleomycin—melanoma	0.000917	0.0047	CcSEcCtD
Amoxapine—Vision blurred—Carmustine—melanoma	0.000917	0.0047	CcSEcCtD
Amoxapine—Tremor—Carmustine—melanoma	0.000912	0.00467	CcSEcCtD
Amoxapine—Oedema—Bleomycin—melanoma	0.00091	0.00466	CcSEcCtD
Amoxapine—Agitation—Carmustine—melanoma	0.000894	0.00458	CcSEcCtD
Amoxapine—Nausea—Vemurafenib—melanoma	0.000892	0.00457	CcSEcCtD
Amoxapine—Thrombocytopenia—Bleomycin—melanoma	0.000891	0.00457	CcSEcCtD
Amoxapine—Vision blurred—Temozolomide—melanoma	0.000886	0.00454	CcSEcCtD
Amoxapine—Tremor—Temozolomide—melanoma	0.000881	0.00452	CcSEcCtD
Amoxapine—Leukopenia—Carmustine—melanoma	0.000871	0.00447	CcSEcCtD
Amoxapine—Anorexia—Bleomycin—melanoma	0.000867	0.00445	CcSEcCtD
Amoxapine—Agitation—Temozolomide—melanoma	0.000864	0.00443	CcSEcCtD
Amoxapine—Hypotension—Bleomycin—melanoma	0.00085	0.00436	CcSEcCtD
Amoxapine—Oedema—Dactinomycin—melanoma	0.000848	0.00435	CcSEcCtD
Amoxapine—Convulsion—Carmustine—melanoma	0.000843	0.00432	CcSEcCtD
Amoxapine—Leukopenia—Temozolomide—melanoma	0.000842	0.00432	CcSEcCtD
Amoxapine—Hypertension—Carmustine—melanoma	0.00084	0.00431	CcSEcCtD
Amoxapine—Palpitations—Temozolomide—melanoma	0.000831	0.00426	CcSEcCtD
Amoxapine—Thrombocytopenia—Dactinomycin—melanoma	0.000831	0.00426	CcSEcCtD
Amoxapine—Paraesthesia—Bleomycin—melanoma	0.000817	0.00419	CcSEcCtD
Amoxapine—Weight increased—Docetaxel—melanoma	0.000817	0.00419	CcSEcCtD
Amoxapine—Convulsion—Temozolomide—melanoma	0.000815	0.00418	CcSEcCtD
Amoxapine—Hypertension—Temozolomide—melanoma	0.000812	0.00416	CcSEcCtD
Amoxapine—Anorexia—Dactinomycin—melanoma	0.000809	0.00415	CcSEcCtD
Amoxapine—Confusional state—Carmustine—melanoma	0.000801	0.00411	CcSEcCtD
Amoxapine—Oedema—Carmustine—melanoma	0.000794	0.00407	CcSEcCtD
Amoxapine—Decreased appetite—Bleomycin—melanoma	0.000791	0.00405	CcSEcCtD
Amoxapine—Acute coronary syndrome—Docetaxel—melanoma	0.000789	0.00404	CcSEcCtD
Amoxapine—Myocardial infarction—Docetaxel—melanoma	0.000784	0.00402	CcSEcCtD
Amoxapine—Dry mouth—Temozolomide—melanoma	0.000783	0.00401	CcSEcCtD
Amoxapine—Stomatitis—Docetaxel—melanoma	0.00078	0.004	CcSEcCtD
Amoxapine—Jaundice—Docetaxel—melanoma	0.00078	0.004	CcSEcCtD
Amoxapine—Thrombocytopenia—Carmustine—melanoma	0.000778	0.00399	CcSEcCtD
Amoxapine—Tachycardia—Carmustine—melanoma	0.000775	0.00397	CcSEcCtD
Amoxapine—Confusional state—Temozolomide—melanoma	0.000774	0.00397	CcSEcCtD
Amoxapine—Oedema—Temozolomide—melanoma	0.000767	0.00393	CcSEcCtD
Amoxapine—Anorexia—Carmustine—melanoma	0.000757	0.00388	CcSEcCtD
Amoxapine—Thrombocytopenia—Temozolomide—melanoma	0.000751	0.00385	CcSEcCtD
Amoxapine—Feeling abnormal—Bleomycin—melanoma	0.00075	0.00384	CcSEcCtD
Amoxapine—Agranulocytosis—Docetaxel—melanoma	0.000747	0.00383	CcSEcCtD
Amoxapine—Hypotension—Carmustine—melanoma	0.000742	0.0038	CcSEcCtD
Amoxapine—Decreased appetite—Dactinomycin—melanoma	0.000738	0.00378	CcSEcCtD
Amoxapine—Fatigue—Dactinomycin—melanoma	0.000731	0.00375	CcSEcCtD
Amoxapine—Anorexia—Temozolomide—melanoma	0.000731	0.00375	CcSEcCtD
Amoxapine—Urticaria—Bleomycin—melanoma	0.000723	0.00371	CcSEcCtD
Amoxapine—Body temperature increased—Bleomycin—melanoma	0.000719	0.00369	CcSEcCtD
Amoxapine—Hepatitis—Docetaxel—melanoma	0.000718	0.00368	CcSEcCtD
Amoxapine—Insomnia—Carmustine—melanoma	0.000718	0.00368	CcSEcCtD
Amoxapine—Hypoaesthesia—Docetaxel—melanoma	0.000715	0.00366	CcSEcCtD
Amoxapine—Paraesthesia—Carmustine—melanoma	0.000713	0.00366	CcSEcCtD
Amoxapine—Somnolence—Carmustine—melanoma	0.000706	0.00362	CcSEcCtD
Amoxapine—Feeling abnormal—Dactinomycin—melanoma	0.000699	0.00358	CcSEcCtD
Amoxapine—Insomnia—Temozolomide—melanoma	0.000694	0.00356	CcSEcCtD
Amoxapine—Gastrointestinal pain—Dactinomycin—melanoma	0.000694	0.00356	CcSEcCtD
Amoxapine—Decreased appetite—Carmustine—melanoma	0.00069	0.00354	CcSEcCtD
Amoxapine—Paraesthesia—Temozolomide—melanoma	0.000689	0.00353	CcSEcCtD
Amoxapine—Somnolence—Temozolomide—melanoma	0.000682	0.0035	CcSEcCtD
Amoxapine—Constipation—Carmustine—melanoma	0.000679	0.00348	CcSEcCtD
Amoxapine—Dyspepsia—Temozolomide—melanoma	0.000676	0.00346	CcSEcCtD
Amoxapine—Abdominal pain—Dactinomycin—melanoma	0.000671	0.00344	CcSEcCtD
Amoxapine—Body temperature increased—Dactinomycin—melanoma	0.000671	0.00344	CcSEcCtD
Amoxapine—Decreased appetite—Temozolomide—melanoma	0.000667	0.00342	CcSEcCtD
Amoxapine—Fatigue—Temozolomide—melanoma	0.000662	0.00339	CcSEcCtD
Amoxapine—Constipation—Temozolomide—melanoma	0.000656	0.00336	CcSEcCtD
Amoxapine—Feeling abnormal—Carmustine—melanoma	0.000654	0.00336	CcSEcCtD
Amoxapine—Asthenia—Bleomycin—melanoma	0.000653	0.00335	CcSEcCtD
Amoxapine—Gastrointestinal pain—Carmustine—melanoma	0.000649	0.00333	CcSEcCtD
Amoxapine—Pruritus—Bleomycin—melanoma	0.000644	0.0033	CcSEcCtD
Amoxapine—Alopecia—Docetaxel—melanoma	0.000635	0.00325	CcSEcCtD
Amoxapine—Feeling abnormal—Temozolomide—melanoma	0.000632	0.00324	CcSEcCtD
Amoxapine—Abdominal pain—Carmustine—melanoma	0.000628	0.00322	CcSEcCtD
Amoxapine—Body temperature increased—Carmustine—melanoma	0.000628	0.00322	CcSEcCtD
Amoxapine—Gastrointestinal pain—Temozolomide—melanoma	0.000628	0.00322	CcSEcCtD
Amoxapine—HTR2A—hindlimb—melanoma	0.000623	0.066	CbGeAlD
Amoxapine—HTR1B—blood vessel—melanoma	0.000619	0.0656	CbGeAlD
Amoxapine—Dysgeusia—Docetaxel—melanoma	0.000612	0.00314	CcSEcCtD
Amoxapine—Urticaria—Temozolomide—melanoma	0.00061	0.00313	CcSEcCtD
Amoxapine—Asthenia—Dactinomycin—melanoma	0.000609	0.00312	CcSEcCtD
Amoxapine—Body temperature increased—Temozolomide—melanoma	0.000607	0.00311	CcSEcCtD
Amoxapine—Abdominal pain—Temozolomide—melanoma	0.000607	0.00311	CcSEcCtD
Amoxapine—Diarrhoea—Dactinomycin—melanoma	0.000581	0.00298	CcSEcCtD
Amoxapine—Vomiting—Bleomycin—melanoma	0.000578	0.00297	CcSEcCtD
Amoxapine—Rash—Bleomycin—melanoma	0.000574	0.00294	CcSEcCtD
Amoxapine—Dermatitis—Bleomycin—melanoma	0.000573	0.00294	CcSEcCtD
Amoxapine—Asthenia—Carmustine—melanoma	0.00057	0.00292	CcSEcCtD
Amoxapine—Syncope—Docetaxel—melanoma	0.000561	0.00288	CcSEcCtD
Amoxapine—Leukopenia—Docetaxel—melanoma	0.00056	0.00287	CcSEcCtD
Amoxapine—Palpitations—Docetaxel—melanoma	0.000553	0.00283	CcSEcCtD
Amoxapine—Asthenia—Temozolomide—melanoma	0.000551	0.00282	CcSEcCtD
Amoxapine—Loss of consciousness—Docetaxel—melanoma	0.00055	0.00282	CcSEcCtD
Amoxapine—Diarrhoea—Carmustine—melanoma	0.000543	0.00279	CcSEcCtD
Amoxapine—Pruritus—Temozolomide—melanoma	0.000543	0.00278	CcSEcCtD
Amoxapine—Convulsion—Docetaxel—melanoma	0.000542	0.00278	CcSEcCtD
Amoxapine—Nausea—Bleomycin—melanoma	0.00054	0.00277	CcSEcCtD
Amoxapine—Hypertension—Docetaxel—melanoma	0.00054	0.00277	CcSEcCtD
Amoxapine—Vomiting—Dactinomycin—melanoma	0.000539	0.00277	CcSEcCtD
Amoxapine—Rash—Dactinomycin—melanoma	0.000535	0.00274	CcSEcCtD
Amoxapine—HTR2A—appendage—melanoma	0.000535	0.0567	CbGeAlD
Amoxapine—Dizziness—Carmustine—melanoma	0.000525	0.00269	CcSEcCtD
Amoxapine—Diarrhoea—Temozolomide—melanoma	0.000525	0.00269	CcSEcCtD
Amoxapine—Dry mouth—Docetaxel—melanoma	0.000521	0.00267	CcSEcCtD
Amoxapine—HTR7—endothelium—melanoma	0.000518	0.0548	CbGeAlD
Amoxapine—Confusional state—Docetaxel—melanoma	0.000515	0.00264	CcSEcCtD
Amoxapine—Oedema—Docetaxel—melanoma	0.00051	0.00262	CcSEcCtD
Amoxapine—Dizziness—Temozolomide—melanoma	0.000507	0.0026	CcSEcCtD
Amoxapine—Vomiting—Carmustine—melanoma	0.000505	0.00259	CcSEcCtD
Amoxapine—Nausea—Dactinomycin—melanoma	0.000504	0.00258	CcSEcCtD
Amoxapine—Shock—Docetaxel—melanoma	0.000502	0.00257	CcSEcCtD
Amoxapine—Rash—Carmustine—melanoma	0.000501	0.00257	CcSEcCtD
Amoxapine—Dermatitis—Carmustine—melanoma	0.0005	0.00256	CcSEcCtD
Amoxapine—Thrombocytopenia—Docetaxel—melanoma	0.0005	0.00256	CcSEcCtD
Amoxapine—Tachycardia—Docetaxel—melanoma	0.000498	0.00255	CcSEcCtD
Amoxapine—Headache—Carmustine—melanoma	0.000497	0.00255	CcSEcCtD
Amoxapine—Vomiting—Temozolomide—melanoma	0.000488	0.0025	CcSEcCtD
Amoxapine—Anorexia—Docetaxel—melanoma	0.000486	0.00249	CcSEcCtD
Amoxapine—Rash—Temozolomide—melanoma	0.000484	0.00248	CcSEcCtD
Amoxapine—Dermatitis—Temozolomide—melanoma	0.000483	0.00248	CcSEcCtD
Amoxapine—Headache—Temozolomide—melanoma	0.000481	0.00246	CcSEcCtD
Amoxapine—HTR7—blood vessel—melanoma	0.000477	0.0506	CbGeAlD
Amoxapine—Hypotension—Docetaxel—melanoma	0.000477	0.00245	CcSEcCtD
Amoxapine—Nausea—Carmustine—melanoma	0.000472	0.00242	CcSEcCtD
Amoxapine—Insomnia—Docetaxel—melanoma	0.000462	0.00237	CcSEcCtD
Amoxapine—Paraesthesia—Docetaxel—melanoma	0.000458	0.00235	CcSEcCtD
Amoxapine—Nausea—Temozolomide—melanoma	0.000456	0.00234	CcSEcCtD
Amoxapine—Somnolence—Docetaxel—melanoma	0.000454	0.00233	CcSEcCtD
Amoxapine—Dyspepsia—Docetaxel—melanoma	0.000449	0.0023	CcSEcCtD
Amoxapine—Desloratadine—ABCB1—melanoma	0.000446	0.315	CrCbGaD
Amoxapine—Decreased appetite—Docetaxel—melanoma	0.000444	0.00227	CcSEcCtD
Amoxapine—Fatigue—Docetaxel—melanoma	0.00044	0.00226	CcSEcCtD
Amoxapine—Constipation—Docetaxel—melanoma	0.000436	0.00224	CcSEcCtD
Amoxapine—Feeling abnormal—Docetaxel—melanoma	0.000421	0.00216	CcSEcCtD
Amoxapine—Gastrointestinal pain—Docetaxel—melanoma	0.000417	0.00214	CcSEcCtD
Amoxapine—Abdominal pain—Docetaxel—melanoma	0.000403	0.00207	CcSEcCtD
Amoxapine—Body temperature increased—Docetaxel—melanoma	0.000403	0.00207	CcSEcCtD
Amoxapine—Asthenia—Docetaxel—melanoma	0.000366	0.00188	CcSEcCtD
Amoxapine—Pruritus—Docetaxel—melanoma	0.000361	0.00185	CcSEcCtD
Amoxapine—Diarrhoea—Docetaxel—melanoma	0.000349	0.00179	CcSEcCtD
Amoxapine—HTR7—neck—melanoma	0.000341	0.0362	CbGeAlD
Amoxapine—Dizziness—Docetaxel—melanoma	0.000337	0.00173	CcSEcCtD
Amoxapine—Vomiting—Docetaxel—melanoma	0.000324	0.00166	CcSEcCtD
Amoxapine—HTR2A—endothelium—melanoma	0.000323	0.0342	CbGeAlD
Amoxapine—DRD3—head—melanoma	0.000322	0.0341	CbGeAlD
Amoxapine—Rash—Docetaxel—melanoma	0.000322	0.00165	CcSEcCtD
Amoxapine—Dermatitis—Docetaxel—melanoma	0.000321	0.00165	CcSEcCtD
Amoxapine—Headache—Docetaxel—melanoma	0.00032	0.00164	CcSEcCtD
Amoxapine—HTR6—head—melanoma	0.00031	0.0329	CbGeAlD
Amoxapine—Nausea—Docetaxel—melanoma	0.000303	0.00155	CcSEcCtD
Amoxapine—HTR2A—blood vessel—melanoma	0.000298	0.0315	CbGeAlD
Amoxapine—Clozapine—CYP1B1—melanoma	0.000291	0.205	CrCbGaD
Amoxapine—HTR2B—skin of body—melanoma	0.000258	0.0273	CbGeAlD
Amoxapine—DRD2—eye—melanoma	0.00024	0.0254	CbGeAlD
Amoxapine—DRD2—retina—melanoma	0.000238	0.0252	CbGeAlD
Amoxapine—DRD1—head—melanoma	0.000231	0.0244	CbGeAlD
Amoxapine—HTR3A—head—melanoma	0.000223	0.0236	CbGeAlD
Amoxapine—HTR2A—neck—melanoma	0.000213	0.0226	CbGeAlD
Amoxapine—HRH1—eye—melanoma	0.00019	0.0201	CbGeAlD
Amoxapine—HTR1B—head—melanoma	0.000187	0.0198	CbGeAlD
Amoxapine—GABRA1—head—melanoma	0.000187	0.0198	CbGeAlD
Amoxapine—SLC6A3—head—melanoma	0.000185	0.0196	CbGeAlD
Amoxapine—HTR2C—head—melanoma	0.000179	0.019	CbGeAlD
Amoxapine—SLC6A4—head—melanoma	0.00017	0.018	CbGeAlD
Amoxapine—CHRM1—head—melanoma	0.000169	0.0179	CbGeAlD
Amoxapine—HTR2B—head—melanoma	0.000168	0.0178	CbGeAlD
Amoxapine—Olanzapine—ALB—melanoma	0.000168	0.118	CrCbGaD
Amoxapine—Olanzapine—ABCB1—melanoma	0.00016	0.113	CrCbGaD
Amoxapine—HTR2A—eye—melanoma	0.000158	0.0168	CbGeAlD
Amoxapine—HTR2A—retina—melanoma	0.000157	0.0166	CbGeAlD
Amoxapine—HTR1A—head—melanoma	0.000151	0.016	CbGeAlD
Amoxapine—HRH1—mammalian vulva—melanoma	0.00015	0.0159	CbGeAlD
Amoxapine—SLC6A2—head—melanoma	0.00015	0.0159	CbGeAlD
Amoxapine—ADRA2A—mammalian vulva—melanoma	0.000148	0.0157	CbGeAlD
Amoxapine—HTR7—head—melanoma	0.000144	0.0153	CbGeAlD
Amoxapine—ORM1—lymph node—melanoma	0.00014	0.0148	CbGeAlD
Amoxapine—ADRA1A—head—melanoma	0.000139	0.0147	CbGeAlD
Amoxapine—DRD2—head—melanoma	0.000136	0.0144	CbGeAlD
Amoxapine—HTR2B—lymph node—melanoma	0.000118	0.0125	CbGeAlD
Amoxapine—HRH1—head—melanoma	0.000108	0.0114	CbGeAlD
Amoxapine—ADRA2A—head—melanoma	0.000106	0.0112	CbGeAlD
Amoxapine—SLC6A2—lymph node—melanoma	0.000105	0.0111	CbGeAlD
Amoxapine—Quetiapine—ABCB1—melanoma	9.7e-05	0.0684	CrCbGaD
Amoxapine—HTR2A—head—melanoma	8.99e-05	0.00953	CbGeAlD
Amoxapine—Diazepam—ALB—melanoma	8.86e-05	0.0624	CrCbGaD
Amoxapine—Diazepam—ABCB1—melanoma	8.45e-05	0.0596	CrCbGaD
Amoxapine—Clozapine—ABCB1—melanoma	8.35e-05	0.0588	CrCbGaD
Amoxapine—CYP2D6—head—melanoma	8.19e-05	0.00868	CbGeAlD
Amoxapine—HRH1—lymph node—melanoma	7.54e-05	0.00799	CbGeAlD
Amoxapine—ADRA2A—lymph node—melanoma	7.4e-05	0.00785	CbGeAlD
Amoxapine—DRD2—Signaling Pathways—CXCL8—melanoma	8.18e-06	2.31e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—AKT1—melanoma	8.17e-06	2.31e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—AKT1—melanoma	8.13e-06	2.3e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—HRAS—melanoma	8.13e-06	2.3e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MYC—melanoma	8.1e-06	2.29e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CXCL8—melanoma	8.05e-06	2.27e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CXCL8—melanoma	8.03e-06	2.27e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CXCL8—melanoma	8.01e-06	2.26e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—HRAS—melanoma	8e-06	2.26e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CDKN1B—melanoma	7.99e-06	2.26e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MYC—melanoma	7.99e-06	2.26e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—PIK3CA—melanoma	7.99e-06	2.26e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—HRAS—melanoma	7.98e-06	2.25e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—PIK3CA—melanoma	7.98e-06	2.25e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—HRAS—melanoma	7.95e-06	2.25e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—KRAS—melanoma	7.93e-06	2.24e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MAPK1—melanoma	7.92e-06	2.24e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—EGFR—melanoma	7.92e-06	2.24e-05	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—AKT1—melanoma	7.9e-06	2.23e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CXCL8—melanoma	7.88e-06	2.23e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTEN—melanoma	7.88e-06	2.22e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—PIK3CA—melanoma	7.86e-06	2.22e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CDKN1B—melanoma	7.86e-06	2.22e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CDKN1B—melanoma	7.84e-06	2.22e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MDM2—melanoma	7.83e-06	2.21e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—HRAS—melanoma	7.83e-06	2.21e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CASP3—melanoma	7.83e-06	2.21e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CDKN1B—melanoma	7.82e-06	2.21e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL2—melanoma	7.82e-06	2.21e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MAPK1—melanoma	7.82e-06	2.21e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—EGFR—melanoma	7.81e-06	2.21e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL6—melanoma	7.78e-06	2.2e-05	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—AKT1—melanoma	7.78e-06	2.2e-05	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—AKT1—melanoma	7.76e-06	2.19e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—PIK3CA—melanoma	7.76e-06	2.19e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CG—melanoma	7.75e-06	2.19e-05	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—AKT1—melanoma	7.73e-06	2.19e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TP53—melanoma	7.72e-06	2.18e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ERBB2—melanoma	7.72e-06	2.18e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TP53—melanoma	7.72e-06	2.18e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CASP3—melanoma	7.7e-06	2.18e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CDKN1B—melanoma	7.7e-06	2.17e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL2—melanoma	7.69e-06	2.17e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CASP3—melanoma	7.69e-06	2.17e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL2—melanoma	7.68e-06	2.17e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CASP3—melanoma	7.66e-06	2.16e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL6—melanoma	7.65e-06	2.16e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL2—melanoma	7.65e-06	2.16e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL6—melanoma	7.64e-06	2.16e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—PIK3CA—melanoma	7.64e-06	2.16e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCND1—melanoma	7.62e-06	2.15e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PIK3CB—melanoma	7.62e-06	2.15e-05	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—AKT1—melanoma	7.61e-06	2.15e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL6—melanoma	7.61e-06	2.15e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—VEGFA—melanoma	7.57e-06	2.14e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CTNNB1—melanoma	7.55e-06	2.13e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CASP3—melanoma	7.54e-06	2.13e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL2—melanoma	7.53e-06	2.13e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—VEGFA—melanoma	7.53e-06	2.13e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TP53—melanoma	7.51e-06	2.12e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCND1—melanoma	7.5e-06	2.12e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL6—melanoma	7.49e-06	2.12e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—STAT3—melanoma	7.49e-06	2.12e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCND1—melanoma	7.48e-06	2.11e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—KRAS—melanoma	7.48e-06	2.11e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PPARG—melanoma	7.48e-06	2.11e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NRAS—melanoma	7.48e-06	2.11e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCND1—melanoma	7.46e-06	2.11e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—STAT3—melanoma	7.45e-06	2.11e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NRAS—melanoma	7.44e-06	2.1e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CTNNB1—melanoma	7.43e-06	2.1e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CTNNB1—melanoma	7.41e-06	2.09e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MMP9—melanoma	7.4e-06	2.09e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—HRAS—melanoma	7.39e-06	2.09e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CTNNB1—melanoma	7.39e-06	2.09e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TP53—melanoma	7.39e-06	2.09e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—KRAS—melanoma	7.38e-06	2.09e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—HRAS—melanoma	7.38e-06	2.08e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CDKN1A—melanoma	7.37e-06	2.08e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PTEN—melanoma	7.36e-06	2.08e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCND1—melanoma	7.34e-06	2.07e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCL8—melanoma	7.32e-06	2.07e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NFKB1—melanoma	7.32e-06	2.07e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—PIK3CA—melanoma	7.29e-06	2.06e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MMP9—melanoma	7.28e-06	2.06e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—HRAS—melanoma	7.28e-06	2.06e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CTNNB1—melanoma	7.27e-06	2.05e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MMP9—melanoma	7.27e-06	2.05e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CDKN1A—melanoma	7.25e-06	2.05e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MMP9—melanoma	7.24e-06	2.05e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CDKN1A—melanoma	7.24e-06	2.05e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PTEN—melanoma	7.24e-06	2.04e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PTEN—melanoma	7.22e-06	2.04e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CDKN1A—melanoma	7.22e-06	2.04e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NFKB1—melanoma	7.2e-06	2.04e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PTEN—melanoma	7.2e-06	2.03e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NFKB1—melanoma	7.19e-06	2.03e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—HRAS—melanoma	7.18e-06	2.03e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—AKT1—melanoma	7.18e-06	2.03e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NFKB1—melanoma	7.17e-06	2.02e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MAPK3—melanoma	7.16e-06	2.02e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CDKN1B—melanoma	7.15e-06	2.02e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MMP9—melanoma	7.13e-06	2.01e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MAPK3—melanoma	7.12e-06	2.01e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CDKN1A—melanoma	7.1e-06	2.01e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PTEN—melanoma	7.09e-06	2e-05	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—AKT1—melanoma	7.07e-06	2e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL6—melanoma	7.07e-06	2e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—HRAS—melanoma	7.06e-06	2e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL6—melanoma	7.06e-06	2e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—AKT1—melanoma	7.06e-06	1.99e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NFKB1—melanoma	7.05e-06	1.99e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TP53—melanoma	7.05e-06	1.99e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—AKT1—melanoma	7.05e-06	1.99e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—AKT1—melanoma	7.02e-06	1.98e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CASP3—melanoma	7.01e-06	1.98e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL2—melanoma	7e-06	1.98e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL6—melanoma	6.96e-06	1.97e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MYC—melanoma	6.96e-06	1.97e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MYC—melanoma	6.93e-06	1.96e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—AKT1—melanoma	6.91e-06	1.95e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—PIK3CA—melanoma	6.87e-06	1.94e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL6—melanoma	6.87e-06	1.94e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCND1—melanoma	6.82e-06	1.93e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CD—melanoma	6.81e-06	1.92e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MAPK1—melanoma	6.81e-06	1.92e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—EGFR—melanoma	6.81e-06	1.92e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—PIK3CA—melanoma	6.78e-06	1.92e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MAPK1—melanoma	6.78e-06	1.91e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—EGFR—melanoma	6.78e-06	1.91e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL6—melanoma	6.76e-06	1.91e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CTNNB1—melanoma	6.76e-06	1.91e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—HRAS—melanoma	6.74e-06	1.91e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ALB—melanoma	6.73e-06	1.9e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TP53—melanoma	6.65e-06	1.88e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—VEGFA—melanoma	6.64e-06	1.88e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MMP9—melanoma	6.62e-06	1.87e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CDKN1A—melanoma	6.6e-06	1.86e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PTEN—melanoma	6.59e-06	1.86e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—STAT3—melanoma	6.58e-06	1.86e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NRAS—melanoma	6.56e-06	1.85e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TP53—melanoma	6.56e-06	1.85e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NFKB1—melanoma	6.55e-06	1.85e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—VEGFA—melanoma	6.54e-06	1.85e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—VEGFA—melanoma	6.52e-06	1.84e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—AKT1—melanoma	6.52e-06	1.84e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—AKT1—melanoma	6.52e-06	1.84e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—VEGFA—melanoma	6.5e-06	1.84e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—STAT3—melanoma	6.47e-06	1.83e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—STAT3—melanoma	6.46e-06	1.82e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NRAS—melanoma	6.46e-06	1.82e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL6—melanoma	6.45e-06	1.82e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NRAS—melanoma	6.44e-06	1.82e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—STAT3—melanoma	6.44e-06	1.82e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—KRAS—melanoma	6.43e-06	1.82e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—AKT1—melanoma	6.42e-06	1.81e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NRAS—melanoma	6.42e-06	1.81e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—VEGFA—melanoma	6.4e-06	1.81e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—KRAS—melanoma	6.4e-06	1.81e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—HRAS—melanoma	6.36e-06	1.8e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—STAT3—melanoma	6.34e-06	1.79e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—AKT1—melanoma	6.34e-06	1.79e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NRAS—melanoma	6.32e-06	1.79e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MAPK3—melanoma	6.29e-06	1.78e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—HRAS—melanoma	6.27e-06	1.77e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—AKT1—melanoma	6.24e-06	1.76e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MAPK3—melanoma	6.18e-06	1.75e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MAPK3—melanoma	6.17e-06	1.74e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MAPK3—melanoma	6.15e-06	1.74e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MYC—melanoma	6.11e-06	1.73e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL6—melanoma	6.09e-06	1.72e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MAPK3—melanoma	6.06e-06	1.71e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MYC—melanoma	6.02e-06	1.7e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL6—melanoma	6.01e-06	1.7e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MYC—melanoma	6e-06	1.7e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MYC—melanoma	5.98e-06	1.69e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MAPK1—melanoma	5.98e-06	1.69e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—EGFR—melanoma	5.98e-06	1.69e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—AKT1—melanoma	5.95e-06	1.68e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—VEGFA—melanoma	5.95e-06	1.68e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CB—melanoma	5.94e-06	1.68e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—PIK3CA—melanoma	5.91e-06	1.67e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MYC—melanoma	5.89e-06	1.66e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—STAT3—melanoma	5.89e-06	1.66e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MAPK1—melanoma	5.88e-06	1.66e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTGS2—melanoma	5.88e-06	1.66e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—EGFR—melanoma	5.88e-06	1.66e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—PIK3CA—melanoma	5.88e-06	1.66e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NRAS—melanoma	5.88e-06	1.66e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MAPK1—melanoma	5.87e-06	1.66e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—EGFR—melanoma	5.87e-06	1.66e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MAPK1—melanoma	5.85e-06	1.65e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—EGFR—melanoma	5.85e-06	1.65e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MAPK1—melanoma	5.76e-06	1.63e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—EGFR—melanoma	5.76e-06	1.63e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TP53—melanoma	5.72e-06	1.62e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TP53—melanoma	5.69e-06	1.61e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—KRAS—melanoma	5.65e-06	1.6e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MAPK3—melanoma	5.63e-06	1.59e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—AKT1—melanoma	5.62e-06	1.59e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—KRAS—melanoma	5.56e-06	1.57e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PIK3CA—melanoma	5.56e-06	1.57e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—KRAS—melanoma	5.55e-06	1.57e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—AKT1—melanoma	5.54e-06	1.57e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—KRAS—melanoma	5.53e-06	1.56e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MYC—melanoma	5.47e-06	1.55e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—HRAS—melanoma	5.47e-06	1.54e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—KRAS—melanoma	5.44e-06	1.54e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—HRAS—melanoma	5.44e-06	1.54e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MAPK1—melanoma	5.35e-06	1.51e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—EGFR—melanoma	5.35e-06	1.51e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL6—melanoma	5.23e-06	1.48e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL6—melanoma	5.21e-06	1.47e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PIK3CA—melanoma	5.19e-06	1.47e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTEN—melanoma	5.13e-06	1.45e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PIK3CA—melanoma	5.11e-06	1.44e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PIK3CA—melanoma	5.1e-06	1.44e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PIK3CA—melanoma	5.08e-06	1.43e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—KRAS—melanoma	5.06e-06	1.43e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TP53—melanoma	5.02e-06	1.42e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PIK3CA—melanoma	5e-06	1.41e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TP53—melanoma	4.94e-06	1.4e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TP53—melanoma	4.93e-06	1.39e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TP53—melanoma	4.91e-06	1.39e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TP53—melanoma	4.84e-06	1.37e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—AKT1—melanoma	4.83e-06	1.36e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—AKT1—melanoma	4.8e-06	1.36e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HRAS—melanoma	4.8e-06	1.36e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—HRAS—melanoma	4.72e-06	1.33e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HRAS—melanoma	4.71e-06	1.33e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HRAS—melanoma	4.7e-06	1.33e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PIK3CA—melanoma	4.65e-06	1.31e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HRAS—melanoma	4.63e-06	1.31e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL6—melanoma	4.6e-06	1.3e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—AKT1—melanoma	4.54e-06	1.28e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL6—melanoma	4.52e-06	1.28e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL6—melanoma	4.51e-06	1.27e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL6—melanoma	4.5e-06	1.27e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TP53—melanoma	4.49e-06	1.27e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL6—melanoma	4.43e-06	1.25e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HRAS—melanoma	4.3e-06	1.21e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AKT1—melanoma	4.24e-06	1.2e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AKT1—melanoma	4.17e-06	1.18e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AKT1—melanoma	4.16e-06	1.18e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AKT1—melanoma	4.15e-06	1.17e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL6—melanoma	4.11e-06	1.16e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AKT1—melanoma	4.08e-06	1.15e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AKT1—melanoma	3.8e-06	1.07e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CA—melanoma	3.62e-06	1.02e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—AKT1—melanoma	2.96e-06	8.36e-06	CbGpPWpGaD
